4:01pm ET
Investing
Chevron, Merck Lift DJIA Wednesday
Chevron, Merck, Exxon, and McDonald's kept the DJIA above water on Wednesday.
Companies
/Healthcare
Merck & Co Inc
$148.35
▼ $1.19 (−0.80%) today
Markets closed · 12:45pm ET
MRK Coverage
Page 34
11:30am ET
Investing
What to Expect From Apple and More Dow Stocks Reporting on Tuesday
24/7 Wall St. has put together a preview of the Dow Jones Industrial Average companies scheduled to report their quarterly results this week.
8:25am ET
Health and Healthcare
Short Sellers Can’t Make Up Their Minds on Major Pharma
The April 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
8:25am ET
Health and Healthcare
Short Sellers Run for Cover From Major Pharma Stocks
The March 31 short interest data have been compared with the previous figures, and short interest decreased in most of these selected pharmaceutical stocks.
8:35am ET
Health and Healthcare
Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote
The March 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks was mixed.
9:15am ET
Health and Healthcare
How Health Care Stocks Responded to the Shelved Health Care Bill
24/7 Wall St. has taken a look at a few companies within the health care sector that might have seen a reaction from the health care vote in Congress, or lack thereof.
4:05pm ET
Investing
DuPont, Chevron Take DJIA Down Thursday
DuPont, Chevron, Merck, and Pfizer sink the DJIA on Thursday.
4:01pm ET
8:55am ET
Investing
Short Sellers Back Off Major Pharma
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
4:01pm ET
Investing
Chevron, Verizon Sink DJIA on Tuesday
Chevron, Verizon, Pfizer, and Merck combined to weigh on the DJIA Tuesday.
9:50am ET
Health and Healthcare
Where Merck and Pfizer’s Type 2 Diabetes Treatment Can Go From Here
Merck and Pfizer each saw their shares sink early on Monday after the firms gave an update on their type 2 diabetes treatment.
8:55am ET
Health and Healthcare
Why Short Sellers Are Making a Massive Bet in Major Pharma
Judging by this report, short sellers are making a tremendous bet against Trump’s plan to reform the health care sector.
12:10pm ET
Health and Healthcare
Merck Delivers Even More Disappointing News in Alzheimer’s Study
Merck saw its shares slip on Wednesday after the firm reported that it will be halting its mid-to-late-stage clinical trial for the treatment of Alzheimer’s disease.
Chris Lange 4:01pm ET
Investing
Apple, JPMorgan Dominate DJIA on Tuesday
JPMorgan, Apple, Merck, and Goldman Sachs all set new 52-week highs and dominated the rising DJIA on Tuesday.
8:35am ET
Health and Healthcare
Are Short Sellers Doubting Trump by Hiking Bets in Major Pharma?
It has yet to be seen how much headway Trump can actually make with heath care reforms, but so far the reaction has been quite positive.